Precigen, Inc. (PGEN) — 8-K Filings

8-K Filings (24)

• Precigen, Inc. Files 8-K on Financials — Nov 13, 2025 Risk: low
  Precigen, Inc. filed an 8-K on November 13, 2025, reporting on its Results of Operations and Financial Condition, as well as Financial Statements and Exhibits.
• Precigen Reports Unregistered Equity Sales — Sep 17, 2025 Risk: medium
  Precigen, Inc. filed an 8-K on September 17, 2025, reporting unregistered sales of equity securities as of September 15, 2025. The filing does not specify the e
• Precigen, Inc. Enters Material Definitive Agreement — Sep 3, 2025 Risk: medium
  On September 3, 2025, Precigen, Inc. entered into a material definitive agreement, creating a direct financial obligation. The company, formerly known as Intrex
• Precigen, Inc. Files 8-K: Regulation FD Disclosure & Exhibits — Aug 18, 2025 Risk: low
  Precigen, Inc. filed an 8-K on August 18, 2025, reporting a Regulation FD Disclosure and Financial Statements and Exhibits. The filing does not contain specific
• Precigen, Inc. Enters Material Definitive Agreement — Aug 18, 2025 Risk: medium
  On August 13, 2025, Precigen, Inc. entered into a material definitive agreement. The company, formerly known as Intrexon Corp, is based in Germantown, Maryland,
• Precigen, Inc. Files 8-K: Director Changes & Officer Compensation Updates — Jun 30, 2025 Risk: medium
  On June 26, 2025, Precigen, Inc. filed an 8-K report detailing several key events. The company announced the departure of a director, the election of a new dire
• Precigen, Inc. Files 8-K on Financials — May 14, 2025 Risk: low
  On May 14, 2025, Precigen, Inc. filed an 8-K report. The filing primarily concerns the company's results of operations and financial condition, as well as finan
• Precigen, Inc. Files 8-K on Financials — Mar 19, 2025 Risk: low
  Precigen, Inc. filed an 8-K on March 19, 2025, reporting on its results of operations and financial condition, and including financial statements and exhibits.
• Precigen, Inc. Files 8-K — Jan 16, 2025 Risk: low
  Precigen, Inc. filed an 8-K on January 16, 2025, reporting other events. The company, formerly known as Intrexon Corp, is incorporated in Virginia and headquart
• Precigen, Inc. Files 8-K: Material Agreements & Equity Changes — Dec 30, 2024 Risk: medium
  On December 27, 2024, Precigen, Inc. entered into a material definitive agreement. The company also reported on unregistered sales of equity securities and mate
• Precigen, Inc. Enters Material Definitive Agreement — Dec 26, 2024 Risk: medium
  On December 18, 2024, Precigen, Inc. entered into a material definitive agreement. The filing does not provide specific details about the agreement, the other p
• Precigen, Inc. Files 8-K on Operations and Financials — Nov 14, 2024 Risk: low
  Precigen, Inc. filed an 8-K on November 14, 2024, reporting on its results of operations and financial condition, as well as financial statements and exhibits.
• Precigen, Inc. Faces Delisting Concerns — Nov 7, 2024 Risk: high
  Precigen, Inc. filed an 8-K on November 7, 2024, to report a Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard. The earliest event
• Precigen, Inc. Terminates Material Definitive Agreement — Oct 10, 2024 Risk: medium
  Precigen, Inc. announced on October 4, 2024, the termination of a material definitive agreement. The company, formerly known as Intrexon Corp, is based in Germa
• Precigen Appoints New CEO, Dr. Helen Torley — Sep 23, 2024 Risk: medium
  Precigen, Inc. announced on September 20, 2024, the appointment of Dr. Helen B. Torley as its new Chief Executive Officer, effective immediately. Dr. Torley, wh
• Precigen Appoints New Director, Sees Board Resignation — Aug 30, 2024 Risk: low
  Precigen, Inc. announced on August 28, 2024, a change in its board of directors. Dr. Helen B. Ribar has been appointed as a new director, and Dr. Robert J. Hari
• Precigen, Inc. Files 8-K on Financials — Aug 14, 2024 Risk: low
  Precigen, Inc. filed an 8-K on August 14, 2024, reporting on its Results of Operations and Financial Condition, as well as Financial Statements and Exhibits. Th
• Precigen, Inc. Enters Material Definitive Agreement — Aug 9, 2024 Risk: medium
  On August 7, 2024, Precigen, Inc. entered into a material definitive agreement. The company, formerly known as Intrexon Corp, is incorporated in Virginia and he
• Precigen, Inc. Files 8-K Report — Aug 6, 2024 Risk: low
  On August 6, 2024, Precigen, Inc. filed an 8-K report detailing significant corporate events. The filing includes information on the company's results of operat
• Precigen, Inc. Announces Board Changes and Officer Compensation Details — Jul 5, 2024 Risk: medium
  On July 5, 2024, Precigen, Inc. filed an 8-K report detailing several key events. The company announced the departure of Dr. Helen R. Ribes from its Board of Di
• Precigen, Inc. Files 8-K on Financials — May 14, 2024 Risk: low
  On May 14, 2024, Precigen, Inc. filed an 8-K report. The filing primarily concerns the company's results of operations and financial condition, along with finan
• Precigen, Inc. Files 8-K on Financials — Mar 19, 2024 Risk: low
  Precigen, Inc. filed an 8-K on March 19, 2024, reporting on its results of operations and financial condition. The filing includes financial statements and exhi
• Precigen CEO Helen Sabzevari to Depart, Transition to Consulting Role — Feb 8, 2024 Risk: medium
  Precigen, Inc. (PGEN) announced on February 2, 2024, that Helen Sabzevari, Ph.D., will step down as President and CEO and resign from the Board of Directors, ef
• Precigen Confirms Nasdaq Global Select Market Listing — Jan 8, 2024
  Precigen, Inc. (PGEN) filed an 8-K on January 8, 2024, to disclose that its common stock, with no par value, is registered on the Nasdaq Global Select Market un

Popular Companies

AAPL · TSLA · MSFT · AMZN · GOOGL · META · NVDA · JPM · BRK-B · V · JNJ · UNH · XOM · WMT · MA · PG · HD · DIS · BAC · NFLX